Allogene Therapeutics(ALLO)
Search documents
Allogene Therapeutics(ALLO) - 2022 Q4 - Annual Report
2023-02-27 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ FORM 10-K _________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38693 _________________________________ Allogen ...
Allogene Therapeutics(ALLO) - 2022 Q3 - Earnings Call Transcript
2022-11-03 03:30
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Christine Cassiano - CCO David Chang - President and CEO Rafael Amado - EVP, Research & Development and CMO Eric Schmidt - CFO Conference Call Participants Andrea Tan - Goldman Sachs Michael Yee - Jefferies Tyler Van Buren - Cowen Asthika Goonewardene - Truist Raju Prasad - William Blair Reni Benjamin - JMP Securities Mark Breidenbach - Oppenheimer John Newman - Canaccord Genuity Micha ...
Allogene Therapeutics(ALLO) - 2022 Q2 - Earnings Call Transcript
2022-08-10 02:36
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President-Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Salveen Richter – Goldman Sachs Michael Yee – Jefferies Kelsey Goodwin – Guggenheim Ren Benjamin – JMP Se ...
Allogene Therapeutics(ALLO) - 2022 Q1 - Earnings Call Transcript
2022-05-05 02:48
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and Chief Executive Officer Rafael Amado - EVP of Research and Development and Chief Medical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Tyler Van Buren - Cowen Cory Kasimov - JP Morgan Salveen Richter - Goldman Sachs John Newman - Canaccord Luca Issi - RBC Capital Kalpit Patel - B. Ril ...